COVID-19 ワクチン接種:これから進む道

Daniel M Altmann¹, Rosemary J Boyton^2,3

¹Department of Immunology and Inflammation, Faculty of Medicine, Hammersmith Hospital Campus, Imperial College London, London, UK.

Science (New York, N.Y.)

|March 10, 2022

まとめ

第1世代のSARS-CoV-2ワクチンはCOVID-19を制御しますが,将来の戦略には,ワクチン強化の最適化と,特に子供に対する新しい変種に対する耐久的な免疫力の開発が必要です.

科学分野:

免疫学
ワクチン学
ウイルス学

背景:

第1世代のSARS-CoV-2ワクチンは,COVID-19のパンデミック管理において極めて重要な役割を果たしています.
ワクチンの不公平な配給は世界的な健康問題です
将来のパンデミックへの備えには,ワクチンの増強と変種保護の課題に取り組む必要があります.

研究の目的:

SARS-CoV-2 ワクチン接種の将来の戦略を評価する.
ワクチンの増強間隔と組成の免疫学的根拠を最適化する.
新興のウイルス変種に対する耐久性のある免疫レパートリーを構築するためのアプローチを探求する.

主な方法:

既存の予防接種戦略と提案された予防接種戦略の比較分析
ワクチンの有効性と耐久性に関する免疫学的データのレビュー
ワクチンの開発における技術的進歩の評価

主要な成果:

ワクチンの技術と生産者の分野はますます多様化しています
祖先ワクチンによる頻繁な増強と,変種特異的または汎コロナウイルスのアプローチの間に議論がある.
小児の予防接種戦略を考慮することは不可欠です.

結論:

ワクチンの増強を最適化し,広範囲の免疫を育成することは,将来のパンデミック制御に不可欠です.
ワクチンの技術と戦略に異質なアプローチが期待されている.
SARS-CoV-2 および将来のコロナウイルスに対する最も効果的な長期のワクチン接種計画を決定するには,さらなる研究が必要です.

さらに関連する動画

08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.7K

08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.0K

関連する概念動画

01:29

Microorganisms in Medicine and Therapeutics

437

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Vaccinations

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

539

01:29

Issues And Trends In Healthcare Delivery System

5.9K

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

5.9K

01:28

Preclinical Development: Overview

5.0K

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

5.0K

02:50

Combination Therapies and Personalized Medicine

5.1K

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...